The effects of halothane (0.5-2%) and enflurane (1-4%) on two Transoxode transcutaneous oxygen (TePO) electrodes (Hellige Servomed Oxymonitor SM.361 system) were serially tested in atmospheres of nitrogen, air and 50% nitrous oxide in oxygen. Both TeP0 2 electrodes reduced and "read" halothane but not enflurane. Calibration drift was significantly greater (p < 0.05) after electrode exposure to halothane; 5.40 s.e.m. 1.37 kPa vs enflurane; -0.60 s. e. m. 0.93 kPa. Halothane has a direct effect in rendering the Transoxode inaccurate, which is probably clinically less important than the indirect cardiovascularly medicated influence of both halothane and enflurane on TeP0 2 levels. A reduction in the electrode polarisation voltage is recommended to obviate the direct effect of halothane on Transoxode performance.
INTRODUCTION
Sequential monitoring of transcutaneous oxygen tension (TcP0 2 ) provides a reliable estimate of trends in central oxygen tension and oxygen availability to tissues in the newborn. 1 -4 However, polarographic oxygen electrodes have been shown to reduce halothane, but not enflurane, both in vitro and in vivo. 5 -IO This study was designed to assess the influence of halothane and enflurane in ambient air, nitrogen and nitrous oxide: oxygen 50:50, on the performance of the Hellige Transoxode. METHODS Two identical Hellige Transoxodes, each with three platinum microcathodes, preheated to a constant temperature of 45 QC by a surrounding thermostatically controlled silver / silver chloride heating anode, were tested. The polarising voltage of the cathodes was 850 mv and the internal electrolyte solution used, silver chloride. The electrode membranes were made of 20 /Am Teflon. The electrodes were linked to a Hellige Servomed Oxymonitor SM. 361 twin modular system with amplifier, and thermostatically controlled anode heating power source, in continuity with a four-channel trend recorder for TcP0 2 and relative heat consumption incorporated in the device.
The two electrodes, placed side by side in a Gregory box at ambient temperature and pressure (Figure 1 ), were exposed to different concentrations of halothane and enflurane in atmospheres of nitrogen, air or nitrous oxide:oxygen 50:50 (Harlake O 2 Analyser). The gases flowed continuously from rotameters at 8 litres per minute, through either a Fluotec Mk. III (Cyprane Ltd.) halothane vaporiser or an Enfluratec (Cyprane Ltd.) enflurane vaporiser into the test chamber. The effects of halothane concentrations ranging from 0.5-2070 in the three gaseous environments were investigated individually on separate days, because halothane had been noted to seriously disturb Transoxode function. Concentrations of enflurane from 1-4% in nitrogen, air and nitrous oxide in oxygen environments were tested in series using a different gaseous atmosphere on three separate occasions, since initial investigation had shown that enflurane did not affect TcP0 2 electrode function.
The changes in TcP0 2 from control to steady state values achieved on exposure to the gas/vapour mixtures were noted. The times taken for initial and maximum responses to halothane were derived from the continuous TcP0 2 recording. Electrode recovery time and calibration drift were also recorded when possible. slowly, but significantly, to the introduction of halothane, (0.5-2%) into the various gaseous invironments (Figures 2-4 ). The degree of response was inconsistent, but appeared doserelated. TcP0 2 readings were also influenced by electrode sensitivity, the latter apparently increasing after electrode servicing. * The average times to initial and maximum peak electrode response to halothane shown in Figure 5 and 6 were prolonged and unpredictable. Recovery times after electrode exposure to halothane were in excess of two hours and appeared sensitivity dependent (both electrodes responded more rapidly and gave higher readings with halothane after recent cleaning polishing and replacement of the membrane. *) Mean calibration drift of the two Recovery time> 2 hours FIGURE 6.-Average time to peak readings of halothane 0.5-2'\10 for two TePO, electrodes in three different gaseous environments. Again variable, with a trend towards dosedependency with air, but not with nitrogen or nitrous oxide:oxygen, thus contrasting with initial response times.
Halothane
(Recovery times, when recorded, were always in excess of two hours.) electrodes after exposure to halothane noted on ten occasions were 5.40 s.e.m. 1.37 kPa.
Enflurane
Enflurane 1-4070 produced no effect on TcP0 2 electrode performance other than an expected dilution of oxygen tension. Mean calibration drift of the three enflurane studies was -0.6 s.e.m. 0.93 kPa, significantly less than that noted with halothane (p < 0.05).
DISCUSSION
Several in vitro studies have shown halothane to be polarographically reduced in standard Clarke-type oxygen electrodes and in both gold and platinum cathode, silver/silver chloride anode oxygen micro-electrodes. 5olO There also exists evidence that halothane anaesthesia interferes with intra-arterial oxygen microcathode and surface P0 2 electrode function. 6 ,9 Halothane probably affects oxygen electrode performance directly in two ways. Halothane vapour is polarographically reduced at the cathode, and simultaneously, electrode sensitivity to oxygen is increased. 9 Both effects might contribute towards inordinately high readings of TcP0 2 in relation to central arterial P0 2 monitoring.
This in vitro study demonstrated that the Hellige Transoxode reduces halothane, causing halothane to be read as oxygen and significant electrode calibration drift. TcP0 2 reading obtained with halothane appeared dosedependant. Both the extent and speed of vapour reduction were influenced by increased electrode sensitivity to halothane after recent servicing.
The reduction of halothane by transcutaneous polarographic oxygen electrodes may be obtunded by reducing the polarising voltage of the P0 2 electrode to 500 mv. 9 The cathode polarising voltage of the two Transoxodes under investigation here was 850 mv and could account for their erratic performance in the presence of halothane vapour, despite the use of silver chloride as the internal electrolyte solution and a teflon membrane. 9 ,11 Anaesthetic gases and vapours, including halothane, have been shown to diffuse outwards percutaneously in limited quantities, 12 particularly from an area of warm, vasodilated, arterialised skin.l The accuracy of the TcP0 2 electrode can thus be directly prejudiced by the transfer of halothane from the capillaries underlying high TcP0 2 recordings. However, these direct effects of halothane are probably of less practical importance than indirect effects due to clinical changes in the patient's haemodynamic status induced by anaesthesia. 9 Decreases in cardiac output and systolic blood pressure will reduce oxygen delivery to Anaesthesia and Intensive Care, Vol. IX, No. 2, May, 1981 tissue and lower TcP0 2 levels, disturbing the degree of correlation between transcutaneous and central arterial Po~, especially in the presence of profound vasoconstriction. 1 ,9,13 Enflurane, by virtue of its similar pharmacological properties to halothane, has a comparable indirect influence on TCP0 2 • 13 These indirect changes could seriously reduce the value of clinical TcP0 2 monitoring during anaesthesia.
